Advertisement

Topics

Forest Laboratories, Inc. and Clinical Data, Inc. Company Profile

03:35 EDT 20th October 2018 | BioPortfolio

Forest Laboratories’ (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-established central nervous system and cardiovascular franchises and innovations in anti-infective medicine. The Company’s pipeline, the most robust in its history, includes product candidates in all stages of development across a wide range of therapeutic areas. The Company is headquartered in New York, NY. To learn more, visit www.FRX.com.


News Articles [2183 Associated News Articles listed on BioPortfolio]

Forest Blow, PTV News: Apr 08, 2010

FDA panel says no to Forest Laboratories' lung drug Daxas

At Wake Forest Baptist Health, What the Mechanics of Clinical Transformation Look Like

Mark HaglandChi Huang, M.D., executive medical director of general medicine, is helping to advance clinical transformation processes at Wake Forest Baptist Health in Winston-Salem, North Carolina

Forest City Seats New Independent Directors

"We are thrilled to welcome our new independent directors to the Forest CityBoard," said David LaRue, President and Chief Executive Officer of Forest Read more...

Wake Forest Baptist receives federal grants to study neurological disorders and stroke

(Wake Forest Baptist Medical Center) The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded Wake Forest Baptist Medical Cente...

ACM acquires ABS to accelerate growth driven by clinical trials, toxicology

ACM Global Laboratories has acquired ABS Laboratories to better serve its clients in the clinical trial market with an expanded "scientific acumen," says company president.

Wake Forest researchers create advanced brain organoid to model strokes, screen drugs

(Wake Forest Baptist Medical Center) Wake Forest Institute for Regenerative Medicine scientists have developed a 3D brain organoid that could have potential applications in drug discovery and disease ...

Joint paper identifies one of Mesoamerica's last intact forest blocks

(Wildlife Conservation Society) The Wildlife Conservation Society (WCS) and Yale University have created a plan to preserve one of the last intact forest strongholds for the jaguar and other iconic sp...

Heterotrophic cultivation of Auxenochlorella protothecoides using forest biomass as a feedstock for sustainable biodiesel production

The aim of this work was to establish a process for the heterotrophic growth of green microalgae using forest biomass hydrolysates. To provide a carbon source for the growth of the green microalgae, t...

PubMed Articles [4765 Associated PubMed Articles listed on BioPortfolio]

Losing sight of the Forest for the trees: Why clinical laboratories need to perform their own interference studies.

Exposure to hepatitis E virus, hepatitis A virus and Borrelia spp. infections in forest rangers from a single forest district in western Poland.

Hepatitis E virus (HEV) infection is an emerging problem in developed countries. At least 2 zoonotic genotypes of the virus (HEV-3 and HEV-4) infect human beings. There are some data suggesting that f...

Results of Laboratory Tests not Accessed in Brazilian Private Laboratories.

Laboratory medicine is an important part of the healthcare system and directly contributes to preventive actions, diagnostics, treatment, and management of diseases. The level and quality of the utili...

Harmonization of microbiology processes and standards: work in progress.

Clinical microbiology is a highly challenging technical discipline, which makes it difficult to harmonize processes and protocols. In addition, the lack of scientific consensus on some diagnostic algo...

Moisture content estimation of forest litter based on remote sensing data.

As a fine fuel, forest litter plays an important role in fire danger rating systems, so forest litter moisture data are necessary and meaningful for fire risk management and prevention. An optical rem...

Clinical Trials [4038 Associated Clinical Trials listed on BioPortfolio]

Attitudes and Knowledge Regarding Clinical Trials in Underserved Populations Receiving Care at the Comprehensive Cancer Center of Wake Forest University

This pilot research trial studies minority patients receiving care at the Comprehensive Cancer Center of Wake Forest University (CCCWFU) to see what their attitudes are regarding the healt...

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers

The purpose of the study is to assess if the antimalarial drugs Dihydroartemisinine + Piperaquine (DP) are effective in preventing malaria infection for forest ranger

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Companies [3618 Associated Companies listed on BioPortfolio]

Forest Laboratories, Inc. and Clinical Data, Inc.

Forest Laboratories’ (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well...

Forest Laboratories, Inc.

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive...

Forest Laboratories

Forest Laboratories develops, manufactures and sells both branded and generic forms of ethical products which require a physician's prescription, as well as non-prescription pharmaceutical products so...

Forest Laboratories, Inc. and Almirall, S.A.

Forest Laboratories' (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-esta...

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

More Information about "Forest Laboratories, Inc. and Clinical Data, Inc." on BioPortfolio

We have published hundreds of Forest Laboratories, Inc. and Clinical Data, Inc. news stories on BioPortfolio along with dozens of Forest Laboratories, Inc. and Clinical Data, Inc. Clinical Trials and PubMed Articles about Forest Laboratories, Inc. and Clinical Data, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Forest Laboratories, Inc. and Clinical Data, Inc. Companies in our database. You can also find out about relevant Forest Laboratories, Inc. and Clinical Data, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record